Table 5. Adjusted ORs (95% CI) for cognitive impairment at 6 months and medication non-adherence at 5 years.

Cognitive impairment at six months post-stroke (MoCA<24)	Non-adherence at five years post-stroke aOR (95% CI)
	Including stroke survivors with probable aphasia			Excluding stroke survivors with probable aphasia (n = 3)
	Prescription refills			p	Prescription refills	p
	Lipid modifiers a	0.09 (0.01, 1.67)		.104	0.09 (0.01, 1.88)	.121
	Antihypertensives b	0.38 (0.07, 2.25)		.289	0.48 (0.08, 3.03)	.436
	Antithrombotics a	0.14 (0.02, 0.90)		.038*	0.16 (0.02, 1.12)	.064
	Self-report			p	Self-report	p
	MARS		0.78 (0.27, 2.25)	.644	0.80 (0.26, 2.48)	.702

^aadjusted for age, sex, stroke severity, Essen stroke risk score.

^bdue to collinearity with stroke severity, this model is adjusted for age, sex, Essen stroke risk score only.

*p < .05.